Effects of peritoneal dialysis on the vascular bed of peritoneal membrane

Contributions to Nephrology

Volumn 150, Issue , 2006, Pages 84-89

  Van Biesen, W ^b   Mortier, S ^b   Lameire, N ^b   De Vriese, An ^a  

^a St Jan Academic Hospital   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

ANIMAL; ANIMAL MODEL; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; HUMAN; MEMBRANE; MICROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; RAT; REVIEW; VASCULARIZATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIALYSIS SOLUTIONS; FIBROSIS; HUMANS; MEMBRANES; MICROSCOPY; MODELS, ANIMAL; PERITONEAL DIALYSIS; PERITONEUM; RATS;

EID: 33745229361     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093506     Document Type: Review

References (21)

1. Ronco C: The 'nearest capillary' hypothesis: a novel approach to peritoneal transport physiology. Perit Dial Int 1996;16:121-125.
2. Rippe B, Stelin G: How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth. Adv Perit Dial 1990;6:13-18.
3. Van Biesen W, Carlsson O, Bergia R, Brauner M, Christensson A, Genestier S, Haag-Weber M, Heaf J, Joffe P, Johansson AC, Morel B, Prischl F, Verbeelen D, Vychytil A: Personal dialysis capacity (PDC(TM)) test: a multicentre clinical study. Nephrol Dial Transplant 2003;18:788-796.
4. Van Biesen W, de Vriese AS, Carlsson O, Van Landschoot M, Dheuvaert T, Lameire NH: Comparison of the radioiodinated serum albumin (RISA) dilution technique with direct volumetric measurements in animal models of peritoneal dialysis. Perit Dial Int 2002;22:316-322.
5. Lameire N, Van Biesen W, Van Landschoot M, Wang T, Heimbürger O, Bergström J, Lindholm B, Hekking LP, Havenith CE, Beelen RH: Experimental models in peritoneal dialysis: a European experience. Kidney Int 1998;54:2194-2206.
6. Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, de Waart R, Hiralall J, Krediet RT: The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995;48:866-875.
7. Kim M, Lofthouse J, Flessner MF: A method to test blood flow limitation of peritoneal-blood solute transport. J Am Soc Nephrol 1997;8:471-474.
8. Davies SJ: Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004;66:2437-2445.
9. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003;S43-S49.
10. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
11. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimbürger O, Lindholm B, Nordfors L, Robert A, Devuyst O: Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005;67:2477-2487.
12. Zweers MM, de Waart DR, Smit W, Struijk DG, Kiediet RT: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 1999;134:124-132.
13. Zweers MM, Splint LJ, Krediet RT, Struijk DG: Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol Dial Transplant 2001;16:651-654.
14. de Vriese AS, Lameire NH: Intravital microscopy: an integrated evaluation of peritoneal function and structure. Nephrol Dial Transplant 2001;16:657-660.
15. de Vriese AS, Tilton RG, Stephan CC, Lameire NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001;12:1734-1741.
16. Mortier S, de Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002;13: 480-489.
17. Mortier S, Faict D, Schalkwijk CG, Lameire NH, de Vriese AS: Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004;66:1257-1265.
18. Mortier S, Faict D, Lameire NH, de Vriese AS: Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005;67:1559-1565.
19. de Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH: Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003;14:2109-2118.
20. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998;101:1219-1224.
21. Treins C, Giorgetti-Peraldi S, Murdaca J, Van Obberghen E: Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 2001;276:43836-43841.